Separating practice guidelines from pharmaceutical marketing
- 1 December 2007
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 35 (12), 2877-2878
- https://doi.org/10.1097/01.ccm.0000288106.55246.a5
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Is industry guiding the sepsis guidelines? A perspectiveCritical Care Medicine, 2007
- The European Society of Intensive Care Medicine (ESICM) and the Surviving Sepsis Campaign (SSC)Intensive Care Medicine, 2007
- Surviving Sepsis — Practice Guidelines, Marketing Campaigns, and Eli LillyThe New England Journal of Medicine, 2006
- Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry DocumentsAnnals of Internal Medicine, 2006
- Health Industry Practices That Create Conflicts of InterestPublished by American Medical Association (AMA) ,2006
- Bioethics, the Surviving Sepsis Campaign, and the industryWiener klinische Wochenschrift, 2005
- Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry — Self-Regulation in the Shadow of Federal ProsecutionThe New England Journal of Medicine, 2004
- The surviving sepsis guidelines: “Lost in translation”*Critical Care Medicine, 2004
- Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shockCritical Care Medicine, 2004
- Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical IndustryPublished by American Medical Association (AMA) ,2002